Serum Institute of India to make £240 mn investments in UK
Serum’s investment will support clinical trials, research and development and possibly manufacturing of vaccines
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
PIL in HC seeks all remdesivir makers be allowed to sell it in domestic market
A bench issued notice to the health ministry, CDSCO, DGFT and various pharma companies, seeking their stand on the plea that…
SII endorses receiving Rs 1,732 crore for 11 crore doses of Covishield vaccine
The company's response came after the Health Ministry in a statement refuted the allegations that it has not placed any fresh…
Safety issues over mass production of COVID vaccines: A techno-legal perspective
Indian pharma giants are producing vaccines in massive quantities. Shrimant Singh, Partner, Singh & Associates and Vijayalaxmi…
Centre has so far provided over 16.54 crore vaccine doses to states/UTs for free
59,70,670 vaccine doses will be received in addition by the states/UTs within the next three days
NATCO receives emergency-use approval for Baricitinib tablets for COVID-19 treatment
Baricitinib, in combination with Remdesivir, is used for treatment of COVID-19-positive patients
Pfizer in talks with India over expedited approval for COVID-19 vaccine
Albert Bourla, CEO, Pfizer also announced a donation of medicines worth more than $70 million
Glenmark launches Ryaltris-AZ in India
It has been launched at a price of Rs 175/- per pack of 75 metered doses
More than 78 lakh COVID vaccine doses still available with states and UTs: Centre
Implementation of the Liberalised and Accelerated Phase 3 Strategy of COVID-19 vaccination started on Saturday, it informed
Dr Reddy’s announces arrival of first consignment of Sputnik V vaccine in India
The rollout of the consignment will be subject to the necessary clearances, which will be processed over the next few days
Cell therapy for solid tumors may get approval by 2022: GlobalData
A total of 298 industry-sponsored trials are currently ongoing investigating cell therapies in non-haematological cancers, says…
No more the pharmacy/vaccine maker of the world?
India has risen like a phoenix before, but this time, this resilience comes at too high a price
AstraZeneca gets US FDA nod for FARXIGA to treat chronic kidney disease
In DAPA-CKD Phase III trial, FARXIGA demonstrated reduction in the risk of the composite of worsening of renal function, end-stage…
WHO issues Emergency Use Listing for Moderna’s COVID-19 vaccine
The EUL pathway involves an assessment of late-stage clinical trial data as well as data on safety, efficacy and quality by…
Hikma Pharma get US FDA nod for higher dosage of naloxone nasal spray to treat opioid overdose
The newly approved product delivers 8 milligrams (mg) of naloxone into the nasal cavity
India to import 4.5 lakh vials of Remdesivir
The government has started importing the vital drug Remdesivir from other countries to ease its shortage in the country
SIDBI launches SHWAS and AROG schemes for COVID preparedness
The schemes facilitate funding to MSMEs for production and services related to supply of oxygen cylinders, oxygen concentrators,…
CMOs gain advantages of COVID-19 production and timescale demands: GlobalData
CMOs signed contract manufacturing service agreements at an unprecedented rate in 2020, says GlobalData
Pharmexcil seeks Indian Ambassador in China’s help on Sichuan Airline issue
Sichuan Airlines recently suspended all its cargo flights to India for 15 days, causing major disruption to private traders'…
Covaxin prices slashed from Rs 600 to Rs 400 per dose for states
The announcement came one day after the Serum Institute of India, reduced the price of Covishield from ₹400 to ₹300